Third Party Net Sales from Continuing Operations of $103.2 million Net Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA [1] from Continuing Operations of $13.1 million; Adjusted EBITDA [1] margin of 12.7% GAAP diluted EPS from Continuing Operations of $(0.11) and adjusted diluted EPS of $0.12 PALM BEACH GARDENS, Fla., Oct. 30, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a... Read More

PALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global Healthcare Conference. Management will be presenting on Tuesday, November 12, 2024 at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available... Read More

PALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024 after market close on Wednesday, October 30, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

Third Party Net Sales from Continuing Operations of $116.8 million Net Loss from Continuing Operations of $(9.6) million; Net Loss margin of (8.2%) Adjusted EBITDA [ 1] from Continuing Operations of $16.1 million; Adjusted EBITDA [1] margin of 13.8% Reduced debt to $235.1 million, ended quarter with cash balance from Continuing Operations of $78.6 million PALM BEACH GARDENS, Fla., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ZimVie... Read More

PALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE ® 5.4 software. The update is now available in all markets where RealGUIDE is sold, enhancing ZimVie’s current RealGUIDE software suite for treatment planning and implant restoration. RealGUIDE 5.4 now helps users manage procedural risk more... Read More

PALM BEACH GARDENS, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced the U.S. launch of its GenTek ® Genuine Restorative Components product portfolio. The launch expands ZimVie’s portfolio of end-to-end prosthetic offerings and follows the recent receipt of FDA 510(k) clearance. ZimVie first launched the GenTek portfolio in Europe in 2019... Read More

PALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024 after market close on Thursday, August 1, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences. ZimVie will be presenting at the upcoming Stifel 2024 Jaws & Paws Conference. ZimVie’s management is scheduled to present on Thursday, May 30, 2024, at 11:30 a.m. Eastern Time. ZimVie’s management... Read More

Third Party Net Sales from Continuing Operations of $118.2 million Net Loss from Continuing Operations of ($11.5) million; Net Loss margin of (9.7%) Adjusted EBITDA [ 1] from Continuing Operations of $12.5 million; Adjusted EBITDA [ 1] margin of 10.5% Completed sale of spine business for $375 million and repaid $275 million of debt on April 1, 2024 PALM BEACH GARDENS, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc.... Read More

PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G. Capital for $375 million in total consideration, including $315 million in cash and a $60 million promissory note. “The completion of the sale of our Spine business is the... Read More

WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. Management will be presenting on Wednesday, April 10 th , 2024 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the event, as well as an archived... Read More

FY 2023 Third Party Net Sales from Continuing Operations of $457.2 million FY 2023 Third Party Net Sales from Discontinued Operations of $409.2 million Updated Reporting Framework: Continuing Operations consists of the Dental Business and the majority of Corporate while Discontinued Operations consists of the Spine Business Advancing plan to complete sale of Spine Business for $375M in total consideration; sale remains on... Read More

WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference... Read More

WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX ® Implant in Japan. As ZimVie’s largest dental implant market in APAC and fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market... Read More

Proposed Sale Establishes a Pure-Play Dental Company with a Leading Implant Portfolio Net Proceeds Will be Used to Pay Down Debt and Support Dental Growth Initiatives WESTMINSTER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading... Read More

WESTMINSTER, Colo., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has received FDA clearance for its Vital™ Spinal Fixation System including instruments for use with Brainlab Spine & Trauma Navigation . This follows the execution of the companies’ Development Cooperation Agreement, announced in March 2023, to achieve... Read More

Third Party Net Sales of $202.9 million Net Loss of ($5.1) million; Net Loss Margin of (2.5%); Adjusted Net Income [1] of $2.2 million Diluted EPS of ($0.19); Adjusted Diluted EPS [1] of $0.08 Adjusted EBITDA [1] of $25.8 million; Adjusted EBITDA margin [1] of 12.7% Ending cash balance of $75.4M as of September 30, 2023 WESTMINSTER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences... Read More

WESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United States has received the newly approved 4.5mm Mobi-C ® Cervical Disc. Introduced in France in 2004, Mobi-C became the first cervical disc approved for one and two levels by the FDA in 2013. The smaller 4.5mm height Mobi-C implants,... Read More

WESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide have been treated with The Tether™ Vertebral Body Tethering System. The Tether was approved as a Humanitarian Device by the FDA in 2019, based on over seven years of clinical data. Over fifty surgeons have performed VBT using the... Read More

WESTMINSTER, Colo., Oct. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of Azure™ Multi-Platform Product Solutions, a comprehensive selection of restorative components to effectively cater to the dental laboratory market. These new offerings are currently available in the United States and select markets in Europe, with... Read More

WESTMINSTER, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the third quarter 2023 after market close on Wednesday, November 1, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

WESTMINSTER, Colo., Oct. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the Biotivity™ A/C Plus Membrane, a growth factor rich membrane used for site coverage and protection from the oral environment in a variety of dental applications. The membrane is now available in the United States. Dental bone grafting... Read More

WESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S. Food and Drug Administration approved its Mobi-C ® Cervical Disc Hybrid Investigational Device Exemption (IDE) application. The decision authorizes ZimVie to begin enrolling U.S. patients in the study, which will follow patients... Read More

ZimVie and Brainlab will cooperate on achieving compatibility between ZimVie’s Vital™ and Virage ® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes WESTMINSTER, Colo., Aug. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has expanded its cooperation agreement with Brainlab , an... Read More

WESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1 st , 2023, the U.S. Food and Drug Administration approved a smaller height of the Mobi-C ® Cervical Disc in seven footprints that will address the anatomical needs of the U.S. patient population. Physicians have used the market-leading Mobi-C device... Read More

Third Party Net Sales of $224.9 million Net Loss of ($23.4) million; Net Loss Margin of (10.4%); Adjusted Net Income [1] of $4.3 million Diluted EPS of ($0.89); Adjusted Diluted EPS [1] of $0.17 Adjusted EBITDA [1] of $29.7 million; Adjusted EBITDA margin [1] of 13.2% WESTMINSTER, Colo., Aug. 02, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported... Read More

WESTMINSTER, Colo., July 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2023 after market close on Wednesday, August 2, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

WESTMINSTER, Colo., May 22, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the company will be participating in the upcoming Stifel 2023 Jaws & Paws Conference in New York. Management will be hosting a presentation on Wednesday, May 31 st , 2023, at 12:40 p.m. Eastern Time / 9:40 a.m. Pacific Time. Stifel’s Jaws & Paws is a leading... Read More

Third Party Net Sales of $225.1 million Net Loss of ($30.0) million; Net Loss Margin of (13.3%); Adjusted Net Income [ 1] of $6.7 million Diluted EPS of ($1.14); Adjusted Diluted EPS [ 1] of $0.25 Adjusted EBITDA [ 1] of $32.1 million; Adjusted EBITDA margin [1] of 14.3% Prepaid required principal debt payment for the first and second quarters of 2024 WESTMINSTER, Colo., May 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq:... Read More

WESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new, state-of-the-art educational facility for dental practitioners in Palm Beach Gardens, Florida. ZimVie Institute South features over 11,000 sq. ft. of dedicated education and training space, offering the latest life-like simulated patient... Read More

WESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions to its biomaterials portfolio, the RegenerOss ® CC Allograft Particulate, a natural blend of cortical and cancellous bone particles that can be used to fill bony voids in a variety of dental applications, and the RegenerOss ®... Read More

WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the first quarter 2023 after market close on Wednesday, May 3, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should register... Read More

WESTMINSTER, Colo., April 03, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that the French Republic has published its approval for the reimbursement of the Mobi-C ® Cervical Disc in both the public and private sectors in France. In addition, the clinical data for Mobi-C was awarded the highest quality rating of 10A* by the Orthopaedic Data... Read More

WESTMINSTER, Colo., March 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the publication of an article titled Comparison of the Effects of Tissue Processing on the Physicochemical Properties of Bone Allografts in The International Journal of Oral & Maxillofacial Implants. ZimVie Dental’s Puros Cancellous Particulate Allograft bone... Read More

WESTMINSTER, Colo., March 15, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that Highmark, one of America's leading health insurance organizations and an independent licensee of the Blue Cross Blue Shield Association, which covers primarily Pennsylvania, New York, Delaware, and West Virginia, and BCBS North Dakota, the largest payer in the... Read More

FY 2022 Third Party Net Sales of $909.5 million FY 2022 Net Loss of ($63.9) million; Net Loss Margin of (7.0%); Adjusted Net Income [ 1] of $47.9 million FY 2022 Diluted EPS of ($2.45); Adjusted Diluted EPS [ 1] of $1.84 FY 2022 Adjusted EBITDA [ 1] of $122.5 million; Adjusted EBITDA margin [1] of 13.5% WESTMINSTER, Colo., March 01, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the... Read More

WESTMINSTER, Colo., Feb. 23, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the RealGUIDE™ CAD and FULL SUITE modules, the latest innovations within ZimVie’s digital dentistry software platform. The CAD (computer-aided design) module introduces advanced software for restorative design and manufacturing, allowing for detailed... Read More

WESTMINSTER, Colo., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full year 2022 after market close on Wednesday, March 1, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should... Read More

WESTMINSTER, Colo., Jan. 30, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 200,000 Mobi-C Cervical Discs have been implanted worldwide. This includes patients treated in over 25 countries since the first surgery was completed with the device in France in 2004. In 2013, Mobi-C became the first cervical disc to win approval from the... Read More

WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California. Vafa Jamali, President and Chief Executive Officer, is scheduled to present on Wednesday, January 11, 2023, at 3:00 p.m. Pacific Time. Interested parties... Read More